Cargando…

Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes

PURPOSE: Health information technology (IT) is an ideal medium to improve the delivery of patient-centered care and increase patient engagement. Health IT interventions should be designed with the end user in mind and be specific to the needs of a given population. Hematopoietic cell transplantation...

Descripción completa

Detalles Bibliográficos
Autores principales: Runaas, Lyndsey, Hoodin, Flora, Munaco, Anna, Fauer, Alex, Sankaran, Roshun, Churay, Tracey, Mohammed, Saara, Seyedsalehi, Sajjad, Chappell, Grant, Carlozzi, Noelle, Fetters, Michael D., Kentor, Rachel, McDiarmid, Leah, Brookshire, Kristina, Warfield, Casiana, Byrd, Michelle, Kaziunas, Sharon, Maher, Molly, Magenau, John, An, Larry, Cohn, Amy, Hanauer, David A., Choi, Sung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873938/
https://www.ncbi.nlm.nih.gov/pubmed/30652535
http://dx.doi.org/10.1200/CCI.17.00110
_version_ 1783472753656987648
author Runaas, Lyndsey
Hoodin, Flora
Munaco, Anna
Fauer, Alex
Sankaran, Roshun
Churay, Tracey
Mohammed, Saara
Seyedsalehi, Sajjad
Chappell, Grant
Carlozzi, Noelle
Fetters, Michael D.
Kentor, Rachel
McDiarmid, Leah
Brookshire, Kristina
Warfield, Casiana
Byrd, Michelle
Kaziunas, Sharon
Maher, Molly
Magenau, John
An, Larry
Cohn, Amy
Hanauer, David A.
Choi, Sung Won
author_facet Runaas, Lyndsey
Hoodin, Flora
Munaco, Anna
Fauer, Alex
Sankaran, Roshun
Churay, Tracey
Mohammed, Saara
Seyedsalehi, Sajjad
Chappell, Grant
Carlozzi, Noelle
Fetters, Michael D.
Kentor, Rachel
McDiarmid, Leah
Brookshire, Kristina
Warfield, Casiana
Byrd, Michelle
Kaziunas, Sharon
Maher, Molly
Magenau, John
An, Larry
Cohn, Amy
Hanauer, David A.
Choi, Sung Won
author_sort Runaas, Lyndsey
collection PubMed
description PURPOSE: Health information technology (IT) is an ideal medium to improve the delivery of patient-centered care and increase patient engagement. Health IT interventions should be designed with the end user in mind and be specific to the needs of a given population. Hematopoietic cell transplantation (HCT), commonly referred to as blood and marrow transplantation (BMT), is a prime example of a complex medical procedure where patient-caregiver-provider engagement is central to a safe and successful outcome. We have previously reported on the design and development of an HCT-specific health IT tool, BMT Roadmap. METHODS: This study highlights longitudinal quantitative and qualitative patient-reported outcomes (PROs) in 20 adult patients undergoing allogeneic HCT. Patients completed PROs at three time points (baseline, day 30 post-HTC, and day 100 post-HCT) and provided weekly qualitative data through semistructured interviews while using BMT Roadmap. RESULTS: The mean hospital stay was 23.3 days (range, 17 to 37 days), and patients had access to BMT Roadmap for a mean of 21.3 days (range, 15 to 37 days). The total time spent on BMT Roadmap ranged from 0 to 139 minutes per patient, with a mean of 55 minutes (standard deviation, 47.6 minutes). We found that patients readily engaged with the tool and completed qualitative interviews and quantitative PROs. The Patient Activation Measure, a validated measure of patient engagement, increased for patients from baseline to discharge and day 100. Activation was significantly and negatively correlated with depression and anxiety PROs at discharge, suggesting that this may be an important time point for intervention. CONCLUSION: Given the feasibility and promising results reported in this study, next steps include expanding our current health IT platform and implementing a randomized trial to assess the impact of BMT Roadmap on critical PROs.
format Online
Article
Text
id pubmed-6873938
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-68739382019-12-03 Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes Runaas, Lyndsey Hoodin, Flora Munaco, Anna Fauer, Alex Sankaran, Roshun Churay, Tracey Mohammed, Saara Seyedsalehi, Sajjad Chappell, Grant Carlozzi, Noelle Fetters, Michael D. Kentor, Rachel McDiarmid, Leah Brookshire, Kristina Warfield, Casiana Byrd, Michelle Kaziunas, Sharon Maher, Molly Magenau, John An, Larry Cohn, Amy Hanauer, David A. Choi, Sung Won JCO Clin Cancer Inform Original Reports PURPOSE: Health information technology (IT) is an ideal medium to improve the delivery of patient-centered care and increase patient engagement. Health IT interventions should be designed with the end user in mind and be specific to the needs of a given population. Hematopoietic cell transplantation (HCT), commonly referred to as blood and marrow transplantation (BMT), is a prime example of a complex medical procedure where patient-caregiver-provider engagement is central to a safe and successful outcome. We have previously reported on the design and development of an HCT-specific health IT tool, BMT Roadmap. METHODS: This study highlights longitudinal quantitative and qualitative patient-reported outcomes (PROs) in 20 adult patients undergoing allogeneic HCT. Patients completed PROs at three time points (baseline, day 30 post-HTC, and day 100 post-HCT) and provided weekly qualitative data through semistructured interviews while using BMT Roadmap. RESULTS: The mean hospital stay was 23.3 days (range, 17 to 37 days), and patients had access to BMT Roadmap for a mean of 21.3 days (range, 15 to 37 days). The total time spent on BMT Roadmap ranged from 0 to 139 minutes per patient, with a mean of 55 minutes (standard deviation, 47.6 minutes). We found that patients readily engaged with the tool and completed qualitative interviews and quantitative PROs. The Patient Activation Measure, a validated measure of patient engagement, increased for patients from baseline to discharge and day 100. Activation was significantly and negatively correlated with depression and anxiety PROs at discharge, suggesting that this may be an important time point for intervention. CONCLUSION: Given the feasibility and promising results reported in this study, next steps include expanding our current health IT platform and implementing a randomized trial to assess the impact of BMT Roadmap on critical PROs. American Society of Clinical Oncology 2018-01-11 /pmc/articles/PMC6873938/ /pubmed/30652535 http://dx.doi.org/10.1200/CCI.17.00110 Text en © 2018 by American Society of Clinical Oncology http://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Reports
Runaas, Lyndsey
Hoodin, Flora
Munaco, Anna
Fauer, Alex
Sankaran, Roshun
Churay, Tracey
Mohammed, Saara
Seyedsalehi, Sajjad
Chappell, Grant
Carlozzi, Noelle
Fetters, Michael D.
Kentor, Rachel
McDiarmid, Leah
Brookshire, Kristina
Warfield, Casiana
Byrd, Michelle
Kaziunas, Sharon
Maher, Molly
Magenau, John
An, Larry
Cohn, Amy
Hanauer, David A.
Choi, Sung Won
Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
title Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
title_full Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
title_fullStr Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
title_full_unstemmed Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
title_short Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
title_sort novel health information technology tool use by adult patients undergoing allogeneic hematopoietic cell transplantation: longitudinal quantitative and qualitative patient-reported outcomes
topic Original Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873938/
https://www.ncbi.nlm.nih.gov/pubmed/30652535
http://dx.doi.org/10.1200/CCI.17.00110
work_keys_str_mv AT runaaslyndsey novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT hoodinflora novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT munacoanna novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT faueralex novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT sankaranroshun novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT churaytracey novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT mohammedsaara novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT seyedsalehisajjad novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT chappellgrant novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT carlozzinoelle novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT fettersmichaeld novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT kentorrachel novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT mcdiarmidleah novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT brookshirekristina novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT warfieldcasiana novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT byrdmichelle novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT kaziunassharon novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT mahermolly novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT magenaujohn novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT anlarry novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT cohnamy novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT hanauerdavida novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes
AT choisungwon novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes